Spero Therapeutics, Inc.
SPRO$136M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaCAMBRIDGE32 employees
Drugs in Pipeline
3
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
SPRO News
Catalyst Timeline
0 upcoming, 1 past
No catalysts found.
Drug Pipeline
TBP-PI-HBr
Urinary Tract Infection
TBPM-PI-HBr
Complicated Urinary Tract Infection
SPR720 500 mg
Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
TBP-PI-HBr | Phase 3 | Urinary Tract Infection | - | - |
TBPM-PI-HBr | Phase 3 | Complicated Urinary Tract Infection | - | - |
SPR720 500 mg | Phase 2 | Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply